Of the 610 cell lines labeled as TP53 mutant based on genomic sequence (see Methods), 87% were classified as having a TP53-loss phenotype (Fig. 4a), suggesting a reasonable ability of the classifier trained on TCGA tumor transcriptomes to generalize to cell line data. This evidence concerns the gene TP53 and neoplasm.